Ranking History
Headlines
- Strong Isis Pharma Outlook
Jun 25, 2008 01:52 PM
- FDA Stings Pharma Big and Small
Jun 23, 2008 12:02 PM
- Investing in microRNA - Beware of Hype, Follow The Money
Jun 04, 2008 01:24 PM
- Market Review for the Week
May 11, 2008 11:26 PM
- 2nd UPDATE: Biogen, Genzyme 1Q Results Strong On Product Sales
Apr 23, 2008 01:13 PM
- Pre-Market
Apr 20, 2008 02:29 PM
- UPDATE: GlaxoSmithKline Signs Regulus Gene Research Deal
Apr 17, 2008 10:21 AM
- GlaxoSmithKline, Regulus Therapeutics In Development Pact
Apr 17, 2008 07:55 AM
- GlaxoSmithKline, Regulus Therapeutics In Development Pact
Apr 17, 2008 07:55 AM
- Rosetta Genomics - Mining Gold Out of Junk
Apr 11, 2008 02:10 AM
- Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer
Jul 17, 2008 10:01 AM
- Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
Jul 01, 2008 07:15 AM
- Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
Jul 01, 2008 07:01 AM
- Isis Pharmaceuticals Conference Call Notice
Jun 30, 2008 10:01 AM
- Regulus Therapeutics Selected for Fierce 15 Top Biotech Companies
Jun 24, 2008 11:02 AM
- Genzyme and Isis Complete Licensing of Mipomersen
Jun 24, 2008 08:03 AM
- Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
Jun 10, 2008 07:01 AM
- Webcast Alert: Isis Pharmaceuticals to Provide General Corporate Update in Conjunction With 2008 Annual Meeting of Stockholders
Jun 03, 2008 07:01 AM
- Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
Jun 02, 2008 09:02 AM
- Isis to Receive $4.6 Million From Alnylam
May 27, 2008 09:51 AM
- Health Winners & Losers: Intuitive Surgical
Jul 23, 2008 04:54 PM
- Genzyme Beats, Holds to Lowered Guidance
Jul 23, 2008 11:54 AM
- Biotech Earnings: Second-Quarter Preview
Jul 11, 2008 10:39 AM
- Genzyme, Isis Cement JV Deal
Jun 24, 2008 11:17 AM
- 'Fast Money' Recap: Oil Boils
Jun 06, 2008 07:22 PM
- Health Winners & Losers: Isis
May 27, 2008 04:26 PM
- 'Fast Money' Recap: Up on the Farm
May 15, 2008 06:55 PM
- Biotech Earnings Review: Celgene, Biogen
May 09, 2008 04:01 PM
- ISIS Pharmaceuticals Closed At Lowest Level Since Late August Friday ISIS
Apr 28, 2008 04:25 AM
- Friday's Winners & Losers: Progenics
Apr 25, 2008 04:34 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ISIS
|
Compare to S&P
|
| YTD |
-2.73 %
|
10.93 %
|
| 4 Weeks |
9.19 %
|
14.22 %
|
| 12 Weeks |
21.78 %
|
34.96 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 37.50 %
|
|
EPS Growth in Last Year: 68.75 %
|
|
Sales Growth in Last Quarter: -13.64 %
|
|
Sales Growth in Last Quarter: 771.59 %
|
|
|
